Accelerated corneal cross-linking using hypo-osmolar riboflavin may be used to treat keratoconus in patients with thin ...
Please provide your email address to receive an email when new articles are posted on . The Dresden protocol for cross-linking has so far shown unmatched results in progressive keratoconus. Results ...
The FDA has expanded clearance for an accelerated treatment protocol for the noninvasive Deep Transcranial Magnetic Stimulation (Deep TMS, BrainsWay) system for depressive episodes and anxiety ...
BURLINGTON, Mass. and JERUSALEM, Sept. 16, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...